Image Eye 01.png

In The Press

Nov 9, 2021

We’ve all heard the statistics: Today, nearly 55 million people suffer from Alzheimer’s disease or related dementias. According to the WHO, dementia is the fastest growing burden on healthcare systems...

Oct 29, 2021

The approval of Biogen’s Alzheimer’s treatment could herald a new generation of therapies, but before that can happen, more investment and better diagnostics may be needed, explains Ben Hargreaves...

Sept 21, 2021

Billionaire philanthropist speaks of the new breakthroughs in diagnostics that are being conducted through Diagnostic Accelerator, a venture that raises philanthropic capital for research in this field...

Sept 20, 2021

Gates Notes

New breakthroughs in Alzheimer’s diagnostics may someday soon let us substantially alter the course of the disease...

June 22, 2021

Dr. Karen Cross was doing everything in her power to prevent her diabetic grandfather from needing an amputation. But that power was limited by distance — Cross works in Toronto and her grandfather was in rural Newfoundland...

Apr 24,2021

With disease-modifying treatments for Alzheimer’s disease potentially on the cusp of approval, there will be pressing demand for quick...

April 20, 2021

Washington, DC (April 20, 2021) – Today, the Global Alzheimer’s Platform Foundation® (GAP) announced eleven biopharma, technology, and nonprofit partners who are contributing to GAP’s Bio-Hermes Study...

Apr 24,2021

With disease-modifying treatments for Alzheimer’s disease potentially on the cusp of approval, there will be pressing demand for quick...

Nov 21,2020

Toronto-based biomedical engineers Eliav Shaked and Roy Kirshon are working on a quick, non-invasive retinal diagnostic for patients decades away from showing symptoms of dementia...

RetiSpec's technology uses a device to perform a simple eye scan, which then can be used to identify the presence of certain disease biomarkers ...

Oct 05, 2020

RetiSpec (Toronto, Canada) is an AI medical imaging company developing tools for the early detection of disease biomarkers in the eye.

25 Oct 2019

RetiSpec technology is hoped to be able to match this early detection ability without the shortcomings of the other approaches. Eliav Shaked, ...

Oct 08, 2019

Disruptive Technology Harnesses Hyperspectral Imagery and Machine-Learning to Allow for Rapid and Cost-Effective Identification of Alzheimer's Biomarkers ...

Oct 08, 2019

Could a simple eye exam detect signs of Alzheimer's disease?

Oct 14, 2019

RetiSpec's technology is designed to identify Alzheimer's biomarkers years before the emergence of clinical symptoms.

2019

A new intiative from the Toronto Memory Project is trying to use retina scans to determine if patient's have Alzheimer's disease

2018/19

CABHI is working with RetiSpec to accelerate its technology in Ontario and Canada. Through the Industry Innovation Partnership Program (I2 P2 ), CABHI matched RetiSpec with the Toronto Memory Program, a medical facility with one of...

 Oct 24, 2018

The University of Minnesota and Toronto-based medical imaging company RetiSpec have announced a collaboration and licensing

17 Oct 2018

The collaboration provides RetiSpec, a startup based in Toronto, Canada, with exclusive access to an imaging system developed by researchers ...